By the histopathological or biochemical assessment of BC cases, invasive BC (IBC) may be categorized into three primary subtypes, namely Luminal, Non-Luminal (human epidermal growth factor receptor 2 (HER2)+), and Triple-negative BC (TNBC). Here, ERBB2 is linked to breast cancer.